284 related articles for article (PubMed ID: 27891685)
1. The DNA aptamer binds stemness-enriched cancer cells in pancreatic cancer.
Kim YJ; Lee HS; Jung DE; Kim JM; Song SY
J Mol Recognit; 2017 Apr; 30(4):. PubMed ID: 27891685
[TBL] [Abstract][Full Text] [Related]
2. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J
Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016
[TBL] [Abstract][Full Text] [Related]
3. In vitro selection of modified RNA aptamers against CD44 cancer stem cell marker.
Ababneh N; Alshaer W; Allozi O; Mahafzah A; El-Khateeb M; Hillaireau H; Noiray M; Fattal E; Ismail S
Nucleic Acid Ther; 2013 Dec; 23(6):401-7. PubMed ID: 24171482
[TBL] [Abstract][Full Text] [Related]
4. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.
Durko L; Wlodarski W; Stasikowska-Kanicka O; Wagrowska-Danilewicz M; Danilewicz M; Hogendorf P; Strzelczyk J; Malecka-Panas E
Dis Markers; 2017; 2017():3276806. PubMed ID: 28659655
[TBL] [Abstract][Full Text] [Related]
5. Screening of aptamers specific to colorectal cancer cells and stem cells by utilizing On-chip Cell-SELEX.
Hung LY; Wang CH; Che YJ; Fu CY; Chang HY; Wang K; Lee GB
Sci Rep; 2015 May; 5():10326. PubMed ID: 25999049
[TBL] [Abstract][Full Text] [Related]
6. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma.
Ferrara B; Dugnani E; Sordi V; Pasquale V; Pellegrini S; Reni M; Balzano G; Piemonti L
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142575
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment.
Wei HJ; Yin T; Zhu Z; Shi PF; Tian Y; Wang CY
Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):428-34. PubMed ID: 21813394
[TBL] [Abstract][Full Text] [Related]
9. RNA aptamers targeting cancer stem cell marker CD133.
Shigdar S; Qiao L; Zhou SF; Xiang D; Wang T; Li Y; Lim LY; Kong L; Li L; Duan W
Cancer Lett; 2013 Mar; 330(1):84-95. PubMed ID: 23196060
[TBL] [Abstract][Full Text] [Related]
10. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
[TBL] [Abstract][Full Text] [Related]
11. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
12. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
13. Development of a panel of DNA Aptamers with High Affinity for Pancreatic Ductal Adenocarcinoma.
Champanhac C; Teng IT; Cansiz S; Zhang L; Wu X; Zhoa Z; Fu T; Tan W
Sci Rep; 2015 Nov; 5():16788. PubMed ID: 26603187
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
Spelt L; Sasor A; Ansari D; Hilmersson KS; Andersson R
Anticancer Res; 2018 Jan; 38(1):313-320. PubMed ID: 29277789
[TBL] [Abstract][Full Text] [Related]
15. Primary and Metastatic Pancreatic Cancer Cells Exhibit Differential Migratory Potentials.
Park JK; Hank T; Scherber CM; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Toner M; Irimia D; Thayer SP; Liss AS
Pancreas; 2020 Jan; 49(1):128-134. PubMed ID: 31856088
[TBL] [Abstract][Full Text] [Related]
16. Extract of the Medicinal Plant Pao Pereira Inhibits Pancreatic Cancer Stem-Like Cell In Vitro and In Vivo.
Dong R; Chen P; Chen Q
Integr Cancer Ther; 2018 Dec; 17(4):1204-1215. PubMed ID: 29985062
[TBL] [Abstract][Full Text] [Related]
17. Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133.
Yin H; Xiong G; Guo S; Xu C; Xu R; Guo P; Shu D
Mol Ther; 2019 Jul; 27(7):1252-1261. PubMed ID: 31085078
[TBL] [Abstract][Full Text] [Related]
18. Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma.
Skoda J; Hermanova M; Loja T; Nemec P; Neradil J; Karasek P; Veselska R
PLoS One; 2016; 11(7):e0159255. PubMed ID: 27414409
[TBL] [Abstract][Full Text] [Related]
19. An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer.
Liu M; Wang Z; Tan T; Chen Z; Mou X; Yu X; Deng Y; Lu G; He N
Theranostics; 2018; 8(20):5772-5783. PubMed ID: 30555580
[TBL] [Abstract][Full Text] [Related]
20. Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray.
Zhu J; He J; Liu Y; Simeone DM; Lubman DM
J Proteome Res; 2012 Apr; 11(4):2272-81. PubMed ID: 22335271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
